Tag: LUPUS 2023
ASX biotech firm Noxopharm unveils anti-inflammatory skin disease drug
Australian biotech company Noxopharm Limited unveiled today its new preclinical product candidate from its Sofra technology platform that has shown effectiveness against inflammatory skin disease in preclinical models
Featured Article
Reality check: Aussie factories’ journey to responsible AI implementation
Artificial intelligence has become more than just a buzzword as it promises to revolutionise every other industry in the world, including manufacturing. In Australia, in particular, the hype surrounding AI and automation has reached a fever pitch, with many business leaders leveraging their resources to race towards adoption and implementation.
